» Authors » Vitor Won-Held Rabelo

Vitor Won-Held Rabelo

Explore the profile of Vitor Won-Held Rabelo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 60
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cesar Cirne-Santos C, Gomes Gonzaga D, Oliveira de Resende G, Goncalves M, Andrade A, Furtado Pacheco P, et al.
Curr Top Med Chem . 2025 Jan; PMID: 39844553
Background: Zika (ZIKV) is a virus transmitted by mosquitoes that can cause Guillain- Barré syndrome and congenital malformations like microcephaly. Given its explosive resurgence and the resulting epidemics in 2016,...
2.
da Rocha N, Dos Santos Correa Amorim L, Rabelo V, da Silva C, Silva L, Barboza G, et al.
Arch Microbiol . 2024 Sep; 206(10):406. PMID: 39292269
Mayaro virus (MAYV) is the causative agent of Mayaro fever, which is characterized mainly by acute fever and long-term severe arthralgia, common manifestations of other arbovirus infections, making the correct...
3.
Francisco Correa de Souza E Souza K, Rabelo V, Abreu P, Santos C, Amaral E Silva N, Luna D, et al.
ACS Omega . 2024 Sep; 9(34):36835-36846. PMID: 39220530
Since 1970 acyclovir (ACV) has been the reference drug in treating herpes simplex virus (HSV) infections. However, resistant herpes simplex virus type 1 (HSV-1) strains have emerged, narrowing the treatment...
4.
Borges A, de Andrade Borges A, Ouverney G, Arruda A, Arruda A, Ribeiro A, et al.
Curr Med Chem . 2024 Jun; 32(2):359-379. PMID: 38877863
Background: Oral squamous cell carcinoma (OSCC) represents the primary form of oral cancer, posing a significant global health threat. The existing chemotherapy options are accompanied by notable side effects impacting...
5.
de Souza Furtado P, Viana G, de Oliveira A, Rabelo V, Cerqueira I, Paschoal C, et al.
Curr Med Chem . 2024 Feb; 32(4):806-824. PMID: 38310396
Introduction: Thrombotic disorders are among the leading causes of morbidity and mortality worldwide. Drugs used in the prevention and treatment of atherothrombosis have pharmacokinetic limitations and adverse effects such as...
6.
Rabelo V, da Silva V, Sanchez Nunez M, Dos Santos Correa Amorim L, Buarque C, Kuhn R, et al.
Future Virol . 2023 Nov; 18(13):865-880. PMID: 37974899
Aim: This work aimed to investigate the antiviral activity of two 1,4-disubstituted-1,2,3-triazole derivatives ( and ) against Chikungunya virus (CHIKV) replication. Materials & Methods: Cytotoxicity was analyzed using colorimetric assays...
7.
Rabelo V, Nunes de Palmer Paixao I, Abreu P
J Mol Model . 2022 Sep; 28(10):311. PMID: 36097090
Chikungunya virus (CHIKV) is the etiological agent of the Chikungunya fever which has spread worldwide. Clinically, this disease may lead to prolonged incapacitating joint pain that can compromise remarkably the...
8.
Costa Zorzanelli B, Ouverney G, Pauli F, da Fonseca A, de Almeida E, de Carvalho D, et al.
Molecules . 2022 Aug; 27(16). PMID: 36014389
Oral squamous cell carcinoma (OSCC) is a global public health problem with high incidence and mortality. The chemotherapeutic agents used in the clinic, alone or in combination, usually lead to...
9.
Antunes S, Rabelo V, Correia Romeiro N
Comput Biol Med . 2021 Aug; 136:104694. PMID: 34365277
Mycobacterium tuberculosis was discovered in 1882 by Robert Koch but, since its discovery, the tuberculosis (TB) epidemic has endured, being one of the top 10 causes of death worldwide. Drug-resistant...
10.
Cavalcanti Chipoline I, da Fonseca A, da Costa G, Pereira de Souza M, Rabelo V, de Queiroz L, et al.
Bioorg Chem . 2020 Jun; 101:103984. PMID: 32554278
The oral squamous cell carcinoma (OSCC) stands out as a public health problem due to its high incidence and low survival rate, despite advances in diagnosis and treatment. Moreover, the...